SMTL ID : 8bwu.1

Crystal structure of SARS-CoV-2 nsp14 methyltransferase domain in complex with the SS148 inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.36 Å

Oligo State

monomer

Ligands

1 x 6NR: (2~{S})-2-azanyl-4-[[(2~{S},3~{S},4~{R},5~{R})-5-(4-azanyl-5-cyano-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methylsulfanyl]butanoic acid(Non-covalent)

6NR.1: 13 residues within 4Å: Chain A: Q.94, G.114, P.116, D.133, A.134, L.147, F.148, Y.149, W.166, N.167, C.168, N.169, V.170 8 PLIP interactions: 8 interactions with chain A Hydrogen bonds: A:Q.94, A:G.114, A:A.134, A:Q.135, A:Y.149, A:Y.149, A:W.166 Water bridges: A:W.166

1 x ZN: ZINC ION(Non-covalent)

ZN.2: 4 residues within 4Å: Chain A: C.233, C.258, C.265, H.268 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.233, A:C.258, A:C.265, A:H.268

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nigam, A. et al., Drug Discovery in Low Data Regimes: Leveraging a Computational Pipeline for the Discovery of Novel SARS-CoV-2 Nsp14-MTase Inhibitors. Biorxiv (2024)

Release Date

2023-10-11

Peptides

Transcription factor ETV6,Proofreading exoribonuclease nsp14: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Transcription factor ETV6,Proofreading exoribonuclease nsp14